Title:
APPLICATION OF HYDROXYSAFFLOR YELLOW A IN PREPARATION OF MEDICATION FOR TREATMENT OR ADJUVANT TREATMENT OF OBESITY DISEASE
Document Type and Number:
WIPO Patent Application WO/2021/017339
Kind Code:
A1
Abstract:
An application of hydroxysafflor yellow A in the preparation of a medication for treatment or adjuvant treatment of an obesity disease.
More Like This:
WO/2006/012135 | QUATERNARY SALT CCR2 ANTAGONISTS |
JP6607924 | Substituted bicyclic compounds |
JPH06183965 | SUPPRESSOR FOR IMMUNOLOGICAL FUNCTION |
Inventors:
YAN DAN (CN)
YANG ZHIRUI (CN)
WANG AITING (CN)
ZHANG LEI (CN)
WANG XIAOFANG (CN)
YANG XINYU (CN)
LIU JUAN (CN)
YUE SHIJUN (CN)
YANG ZHIRUI (CN)
WANG AITING (CN)
ZHANG LEI (CN)
WANG XIAOFANG (CN)
YANG XINYU (CN)
LIU JUAN (CN)
YUE SHIJUN (CN)
Application Number:
PCT/CN2019/120933
Publication Date:
February 04, 2021
Filing Date:
November 26, 2019
Export Citation:
Assignee:
BEIJING SHIJITAN HOSPITAL CAPITAL MEDICAL UNIV (CN)
International Classes:
A61K31/351; A61P3/04
Foreign References:
CN110215450A | 2019-09-10 | |||
CN102657639A | 2012-09-12 |
Other References:
YU, TAO: "Influence of HYSA on Steroid-induced BMSCs Adipogenic Differentiation", JOURNAL OF FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, vol. 21, no. 6, 1 December 2011 (2011-12-01), pages 24 - 27, XP055777590, DOI: 10.13261/j.cnki.jfutcm.002574
XIUYING GAO, CAIHONG GUO, WEI ZHU: "Improving Effect of Safflor Yellow on Fatty Liver and Insulin Resistance in Obese Mic", CHINA PHARMACIST, vol. 20, no. 1, 1 January 2017 (2017-01-01), pages 86 - 90, XP055777597
XIUYING GAO, CAIHONG GUO, WEI ZHU: "Improving Effect of Safflor Yellow on Fatty Liver and Insulin Resistance in Obese Mic", CHINA PHARMACIST, vol. 20, no. 1, 1 January 2017 (2017-01-01), pages 86 - 90, XP055777597
Attorney, Agent or Firm:
BEIJING EASTKING PATENT AGENT FIRM (CN)
Download PDF: